Cargando…

Cell fate determination in cisplatin resistance and chemosensitization

Understanding the determination of cell fate choices after cancer treatment will shed new light on cancer resistance. In this study, we quantitatively analyzed the individual cell fate choice in resistant UM-SCC-38 head and neck cancer cells exposed to cisplatin. Our study revealed a highly heteroge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luong, Khanh V., Wang, Ling, Roberts, Brett J., Wahl, James K., Peng, Aimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029634/ https://www.ncbi.nlm.nih.gov/pubmed/26993599 http://dx.doi.org/10.18632/oncotarget.8110

Ejemplares similares

Dacomitinib improves chemosensitivity of cisplatin-resistant human ovarian cancer cells
por: Xu, Lei, et al.
Publicado: (2021)

Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors
por: Crean-Tate, Katie K., et al.
Publicado: (2021)

eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma
por: Liu, Ting, et al.
Publicado: (2016)

Chemosensitizing and nephroprotective effect of resveratrol in cisplatin –treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2015)

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
por: Gąsiorkiewicz, Bartosz Mateusz, et al.
Publicado: (2020)

Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells
por: Sun, Lichun, et al.
Publicado: (2021)

MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species
por: VERA-PUENTE, OLGA, et al.
Publicado: (2018)

In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
por: Mellish, K. J., et al.
Publicado: (1993)

Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma
por: Suksawat, Manida, et al.
Publicado: (2022)

sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo
por: Ma, Guoliang, et al.
Publicado: (2015)

Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway
por: Dong, Hao, et al.
Publicado: (2017)

A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma
por: Wu, Mengjiao, et al.
Publicado: (2019)

Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin
por: Xu, Xiaohui, et al.
Publicado: (2020)

MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016)

The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin
por: Zhang, Xinyue, et al.
Publicado: (2017)

MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1
por: Chen, Liqiang, et al.
Publicado: (2020)

ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer
por: Li, Ching-Chia, et al.
Publicado: (2015)

Correction to: Chemosensitizing and nephroprotective effect of resveratrol in cisplatin-treated animals
por: Osman, Abdel-Moneim M., et al.
Publicado: (2019)

The deacetylation of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin
por: Wang, Xi‐wen, et al.
Publicado: (2021)

The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells
por: Mukherjee, Sudeshna, et al.
Publicado: (2017)

MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells
por: Cimas, Francisco J., et al.
Publicado: (2015)

Effects of NOB1 on the pathogenesis of osteosarcoma and its expression on the chemosensitivity to cisplatin
por: Luo, Leiming, et al.
Publicado: (2018)

VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin
por: YAO, RUCHENG, et al.
Publicado: (2014)

Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cells
por: Tortelli, Tharcisio Citrangulo, et al.
Publicado: (2021)

GRP78/BiP determines senescence evasion cell fate after cisplatin-based chemotherapy
por: Ei, Zin Zin, et al.
Publicado: (2021)

Testis developmental related gene 1 regulates the chemosensitivity of seminoma TCam‐2 cells to cisplatin via autophagy
por: Peng, Dongyi, et al.
Publicado: (2019)

S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism
por: Zhao, Chuchu, et al.
Publicado: (2018)

Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53
por: Liu, Rongfeng, et al.
Publicado: (2021)

Atorvastatin potentiates the chemosensitivity of human liver cancer cells to cisplatin via downregulating YAP1
por: Guo, Liwen, et al.
Publicado: (2021)

Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models
por: Thanee, Malinee, et al.
Publicado: (2021)

METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
por: Li, Ruyi, et al.
Publicado: (2021)

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer
por: Murphy, Neal, et al.
Publicado: (2022)

Cx25 contributes to leukemia cell communication and chemosensitivity
por: Sinyuk, Maksim, et al.
Publicado: (2015)

Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells
por: Lin, Che-Yi, et al.
Publicado: (2017)

Apollon modulates chemosensitivity in human esophageal squamous cell carcinoma
por: Zhang, Si, et al.
Publicado: (2014)

MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4
por: Ning, Fang-ling, et al.
Publicado: (2014)

PRDM14 mediates chemosensitivity and glycolysis in drug-resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells
por: He, Saifei, et al.
Publicado: (2021)

Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)
por: Glaysher, Sharon, et al.
Publicado: (2009)

MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2
por: Liu, Yang, et al.
Publicado: (2017)

Overexpression of Ulk2 inhibits proliferation and enhances chemosensitivity to cisplatin in non-small cell lung cancer
por: Cheng, Hong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_69jcic8lcha7dsnp4r09t66vg3